Blood Flow Restriction Exercise-induced Hypoalgesia
Launched by UNIVERSITY OF VALENCIA · Apr 4, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help reduce pain for adults who have had surgery to repair a rotator cuff injury. The researchers want to find out if doing specific exercises with a technique called blood flow restriction (BFR) will help people feel less pain compared to just doing the exercises alone. Participants will be randomly assigned to try both methods over a couple of weeks, with breaks in between. They will be monitored for changes in pain levels and other factors related to their recovery.
To join the study, you must be between 40 and 65 years old and have a diagnosed rotator cuff tear that requires surgery. You should also be able to read and understand Spanish. However, certain conditions, like previous serious injuries or certain medical histories, would make you ineligible. If you decide to participate, you can expect to attend sessions where you will perform the exercises and provide feedback on your pain and recovery experience. This trial is not yet recruiting, but it aims to gather important information about improving recovery after rotator cuff surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 40-65 years.
- • Symptomatic degenerative rotator cuff tear diagnosed by magnetic resonance imaging.
- • Undergoing arthroscopic rotator cuff repair
- • Be able to read and understand Spanish.
- Exclusion Criteria:
- • Massive irreparable RC tears, concomitant fracture, labral or nerve injury.
- • Suspicion of developing/diagnosis a frozen shoulder.
- • Revision surgery after RC repair.
- • Previous corticosteroid injection (\< 1 year).
- • Recent surgery (\< 1 year) in the contralateral shoulder.
- • A history of deep venous thrombosis/pulmonary embolism.
- • Peripheral vascular disease, thrombophilia or clotting disorders.
- • Severe or uncontrolled hypertension, or any comorbid condition that prevents participants from complete the intervention.
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Temuco, Cautín, Chile
Temuco, , Chile
Patients applied
Trial Officials
Felipe Ponce-Fuentes, MSc
Principal Investigator
Universidad Mayor
Jose Casaña, PhD
Study Director
University of Valencia
Joaquin Calatayud, PhD
Study Director
University of Valencia
Filip Struyf, PhD
Study Director
Universiteit Antwerpen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported